Bessemer Group’s VolitionRx Ltd VNRX Stock Holding History

Bessemer Group’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500	Closed	-$31K	–	1830
2019 Q2	$31K	Hold	500	–	–	﹤0.01%	1376
2019 Q1	$33K	Hold	500	–	–	﹤0.01%	1350
2018 Q4	$18K	Hold	500	–	–	﹤0.01%	1541
2018 Q3	$26K	Hold	500	–	–	﹤0.01%	1408
2018 Q2	$20K	Hold	500	–	–	﹤0.01%	1410
2018 Q1	$24K	Hold	500	–	–	﹤0.01%	1371
2017 Q4	$29K	Hold	500	–	–	﹤0.01%	1352
2017 Q3	$26K	Hold	500	–	–	﹤0.01%	1426
2017 Q2	$35K	Hold	500	–	–	﹤0.01%	1376
2017 Q1	$40K	Hold	500	–	–	﹤0.01%	1344
2016 Q4	$46K	Buy	+500	New	+$44.8K	﹤0.01%	1366

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bessemer Group's VNRX Position: Q3 2019 in Review

Bessemer Group sold out of VolitionRx Ltd (VNRX) in Q3 2019, closing a stake of 500 shares — an estimated $31K sold.

Bessemer Group first reported a position in VNRX in Q4 2016 and held it in 11 quarters. The position peaked at $46K in Q4 2016. 31 funds tracked by Wall St. Rank hold VNRX as of Q3 2019.

Bessemer Group reported no remaining VolitionRx Ltd position as of Q3 2019 after selling out during the quarter.
Bessemer Group sold 500 VolitionRx Ltd shares in Q3 2019, an estimated $31K.
Bessemer Group first reported a position in VolitionRx Ltd in Q4 2016 and held it in 11 quarters.
Bessemer Group's VolitionRx Ltd position peaked at $46K in Q4 2016.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2019.

Based on Bessemer Group's 13F filing for Q3 2019, filed 7 Nov 2019.